IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Asymmetry Capital Management, L.P.

Q3 2015 Holdings

Filed 2015-11-09 | 22 holdings | $44.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Davita Healthcare Partners I(DVA)COM23918K108$4.1K56,2909.1%
Edwards Lifesciences Corp(EW)COM28176E108$3.9K27,5748.7%
Quest Diagnostics Inc(DGX)COM74834L100$3.7K60,5208.3%
Amicus Therapeutics Inc(FOLD)COM03152W109$3.3K232,9577.3%
Nevro Corp(NVROEUR)COM64157F103$2.9K61,6606.4%
Centene Corp(CNC)COM15135B101$2.8K50,7846.1%
Teva Pharmaceutical(TEVA)ADR881624209$2.7K48,0856.0%
Stryker Corp(SYK)COM863667101$2.6K27,7815.8%
Mimedx Group Inc(MDXG)COM602496101$2.2K229,8394.9%
Neurocrine Biosciences Inc(NBIX)COM64125C109$2.0K49,5004.4%
Endo International PLCCOM29264F205$1.8K26,6004.1%
Bristol-Myers Squibb Co(BMY)COM110122108$1.8K29,9003.9%
Aerie Pharmaceuticals Inc(AERIEUR)COM00771V108$1.5K85,8343.4%
Clovis Oncology Inc(CLVSEUR)COM189464100$1.5K16,4583.4%
Sagent Pharmaceuticals IncCOM786692103$1.4K92,2133.1%
Impax Laboratories IncCOM45256B101$1.3K38,2793.0%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$1.3K118,7073.0%
Xenoport IncCOM98411C100$1.3K368,3952.8%
Anacor Pharmaceuticals IncCOM32420101$1.1K9,3492.5%
Synergy Pharmaceuticals IncCOM871639308$1.1K203,1552.4%
Penumbra Inc(PEN)COM70975L107$4009,9800.9%
Epirus Biopharmaceuticals inCOM29428P107$18942,7870.4%